Steven Radoff
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
Papers in
-
- Glycosylation and Glycoproteins Research 6
- Fibroblast Growth Factor Research 4
-
- Proteoglycans and glycosaminoglycans research 7
- Co-authors
- Helen Vlassara (8 shared papers)Zenji Makita (3 shared papers)Anthony Cerami (5 shared papers)Edward Y. Skolnik (2 shared papers)Martina Kirstein (2 shared papers)Elliot J. Rayfield (1 shared paper)Zhi Yang (1 shared paper)Eli A. Friedman (1 shared paper)
- Journals
- Diabetes (3 papers)Archives of Biochemistry and Biophysics (3 papers)Journal of Biological Chemistry (2 papers)New England Journal of Medicine (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Steven Radoff
15 papers receiving 1.4k citations
Steven Radoff's Hit Papers
Peers
Comparison fields: 5 of 93
- Clinical Biochemistry 1.0k
- Nephrology 306
- Endocrinology, Diabetes and Metabolism 589
- Neurology 106
- Pathology and Forensic Medicine 180
Countries citing papers authored by Steven Radoff
This map shows the geographic impact of Steven Radoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Radoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Radoff more than expected).
Fields of papers citing papers by Steven Radoff
This network shows the impact of papers produced by Steven Radoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Radoff. The network helps show where Steven Radoff may publish in the future.
Co-authors
The 17 scholars most cited alongside Steven Radoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Advanced Glycosylation End Products in Patients with Diabetic Nephropathy Hit paper breakdown → | 1991 | 740 |
| 2 | 1990 | 310 | |
| 3 | 1991 | 206 | |
| 4 | 1990 | 53 | |
| 5 | 1988 | 45 | |
| 6 | 1984 | 33 | |
| 7 | 1991 | 25 | |
| 8 | 1982 | 20 | |
| 9 | 1981 | 16 | |
| 10 | 1990 | 13 | |
| 11 | 1982 | 10 | |
| 12 | 1985 | 7 | |
| 13 | 1985 | 5 | |
| 14 | 1979 | 2 | |
| 15 | Isolation of a macrophage receptor for proteins modified by advanced glycosylation end products | 1987 | 1 |
About Steven Radoff
Steven Radoff is a scholar working on Molecular Biology, Cell Biology, Clinical Biochemistry, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (7 papers), Advanced Glycation End Products research (6 papers), Glycosylation and Glycoproteins Research (6 papers), Fibroblast Growth Factor Research (4 papers), Cell Adhesion Molecules Research (3 papers), Protease and Inhibitor Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Clinical Biochemistry (1.0k citations), Nephrology (306 citations), Endocrinology, Diabetes and Metabolism (589 citations), Neurology (106 citations) and Pathology and Forensic Medicine (180 citations). Steven Radoff has collaborated with scholars based in United States. Frequent co-authors include Helen Vlassara, Zenji Makita, Anthony Cerami, Edward Y. Skolnik, Martina Kirstein, Elliot J. Rayfield, Zhi Yang, Eli A. Friedman, Vera Delaney and J Brett. Their work appears in journals such as Diabetes, Archives of Biochemistry and Biophysics, Journal of Biological Chemistry, New England Journal of Medicine and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.